Literature DB >> 1548065

Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.

M A Powles1, D C McFadden, L A Pittarelli, D M Schmatz.   

Abstract

Animal models for Pneumocystis carinii, for the most part, have been limited to immunosuppressed rats and ferrets, while a dependable mouse model has been more difficult to develop. A P. carinii mouse model has now been established with several strains of mice, including C3Heb/FeJ, C3HeN, BALB/c, DBA/2N, and BALB/c nu/nu (athymic). In lieu of using invasive methods for initiating P. carinii infections, mice harboring P. carinii transmitted the disease to mice without latent infection via short-term cohabitation. After the exposure period, the seed mice were sacrificed to confirm the presence of acute P. carinii pneumonia. Acute infections in recipient mice developed at approximately 7 to 8 weeks, while control unseeded littermates remained uninfected. All recipient mice and their littermates were maintained in isolation hoods to eliminate the possibility of exposure to other sources of P. carinii. This approach allows investigators to consistently transmit P. carinii to mice and to select the strain of mouse desired for use in a particular study. The results presented here suggest that more attention should be given to the potential for patient-to-patient transmission of P. carinii in immunocompromised patients such as those with AIDS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548065      PMCID: PMC257010          DOI: 10.1128/iai.60.4.1397-1400.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  A NEW PROCEDURE FOR THE IDENTIFICATION OF PNEUMOCYSTIS CARINII CYSTS IN TISSUE SECTIONS AND SMEARS.

Authors:  A M CHALVARDJIAN; L A GRAWE
Journal:  J Clin Pathol       Date:  1963-07       Impact factor: 3.411

2.  Pneumocystis carinii pneumonia in scid/scid mice.

Authors:  L D Shultz; P A Schweitzer; E J Hall; J P Sundberg; S Taylor; P D Walzer
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

3.  Has the incidence of Pneumocystis carinii pneumonia in cancer patients increased with the AIDS epidemic?

Authors:  E Haron; G P Bodey; M A Luna; R Dekmezian; L Elting
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

4.  Pneumocystis carinii pneumonia: a cluster of eleven cases.

Authors:  C Singer; D Armstrong; P P Rosen; D Schottenfeld
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

5.  An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia.

Authors:  T K Ruebush; R A Weinstein; R L Baehner; D Wolff; M Bartlett; F Gonzles-Crussi; A J Sulzer; M G Schultz
Journal:  Am J Dis Child       Date:  1978-02

6.  Nude mouse: a new experimental model for Pneumocystis carinii infection.

Authors:  P D Walzer; V Schnelle; D Armstrong; P P Rosen
Journal:  Science       Date:  1977-07-08       Impact factor: 47.728

7.  A natural source of infection due to pneumocystis carinii.

Authors:  W T Hughes; D L Bartley; B M Smith
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

8.  New rat model of Pneumocystis carinii infection.

Authors:  M S Bartlett; J A Fishman; S F Queener; M M Durkin; M A Jay; J W Smith
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

9.  An outbreak of Pneumocystis carinii pneumonia at a pediatric hospital.

Authors:  M J Chusid; K A Heyrman
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

10.  Spontaneous wasting disease in nude mice associated with Pneumocystis carinii infection.

Authors:  E C Weir; D G Brownstein; S W Barthold
Journal:  Lab Anim Sci       Date:  1986-04
View more
  13 in total

1.  Natural transmission of Pneumocystis carinii in nonimmunosuppressed animals: early contagiousness of experimentally infected rabbits (Oryctolagus cuniculus).

Authors:  N Ceré; B Polack; N K Chanteloup; P Coudert
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 2.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 3.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

4.  Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.

Authors:  P D Walzer; J Runck; P Steele; M White; M J Linke; C L Sidman
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 5.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.

Authors:  Sadhna M Shankar; Joseph J Nania
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice.

Authors:  D C McFadden; M A Powles; J G Smith; A M Flattery; K Bartizal; D M Schmatz
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.

Authors:  M S Bartlett; W L Current; A Orazi; N L Bauer; R S Neiman; S F Queener; J W Smith
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

9.  Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques.

Authors:  Heather M Kling; Timothy W Shipley; Sangita Patil; Alison Morris; Karen A Norris
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

10.  Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study.

Authors:  Elodie Senggen Manoloff; Patrick Francioli; Patrick Taffé; Guy Van Melle; Jacques Bille; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.